Skip to content

Effect of shwadamstravarunadi kwatha in mutrashmari (urolithiasis)

A clinical study to evaluate the effect of shwadamstravarunadi kwatha in the management of the mutrashmari w.s.r to urolithiasis - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059456
Enrollment
30
Registered
2023-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

None listed

Sponsors

Dr Sangappa
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with Samanya Lakshana of Mutrashmari. Size of stone upto 9 mm. Patient willing to sign consent form.

Exclusion criteria

Exclusion criteria: Known case of severe systemic disorder like Renal failure, Tuberculosis, Hydronephrosis, Pylonephrosis, Polycystic Kidney disease, Wilms tumor and Others Neoplasm. Known case of Urinary obstructive symptoms. Known case of Hyperparathyroidism.

Design outcomes

Primary

MeasureTime frame
Effect of trial drug on Reducing symptoms of Mutrashmari(Urolithiasis) and with changes in size of Calculi as per USG DiagnosticsTimepoint: 7day, 15day, 30day

Secondary

MeasureTime frame
Adverse drug reaction of trial drug & Increase in the symptoms of Mutrashmari(Urolithiasis)Timepoint: 7day, 15day, 30day

Countries

India

Contacts

Public ContactDr Sangappa

SidramappaDanigond Memorial Trusts Ayurvedic Medical College Post Graduation Centre

shivabalaraddi@gmail.com9611096696

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026